Clinical trials demonstrate that cumulative weight loss increases across the dose range, but individual response varies based on metabolism, genetics, and gastrointestinal tolerance
Glucagon receptor biology is better-characterized in the liver than in other tissues, and the metabolic effects of GCGR activation in adipose, skeletal muscle, and CNS are active research areas
Fresh semaglutide solution is typically clear and colorless, though some formulations with B12 may have a slight pink or reddish tint
Typically, GLP-1 receptor agonists are recommended for individuals with a BMI of 30 kg/m or higher, classified as obesity, or for those with a BMI of at least 27 kg/m who also have obesity-related health conditions such as hypertension, type 2 diabetes , or high cholesterol
Isolated case reports have described elevations in liver enzymes or rare instances of liver-related adverse events in patients taking semaglutide